Concepedia

Efficacy and safety of antibody induction therapy in the current era of kidney transplantation

Gerhard Opelz, Christian Unterrainer, Caner Süsal, Bernd Döhler

Nephrology Dialysis Transplantation · 2016 · 38 citations · 17 references

DOIFull text

Open access

Abstract

Induction therapy following kidney transplantation should be targeted to increased-risk transplants. In this analysis, a beneficial effect of antibody induction in normal-risk transplants could not be demonstrated.

References

17

KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary

Bertram L. Kasiske, Martin Zeier, Jeremy R. Chapman et al. · Kidney International · 2009 · 1.7K citations

, , +9

Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

Kai‐Uwe Eckardt, Bertram L. Kasiske, Martin Zeier · American Journal of Transplantation · 2009 · 1.4K citations

, , +8

Multivariate and Propensity Score Matching Software with Automated Balance Optimization: The<b>Matching</b>Package for<i>R</i>

Jasjeet S. Sekhon · Journal of Statistical Software · 2011 · 1.4K citations · Full text

, , +11

Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation

Brian D. Tait, Caner Süsal, Howard M. Gebel et al. · Transplantation · 2012 · 760 citations

Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplantation

Daniel C. Brennan, John A. Daller, Kathleen D. Lake et al. · New England Journal of Medicine · 2006 · 721 citations · Full text